Clinical Trial Update: Safety and Efficacy Study of Vaccine Schedule With Ad26.Mos.HIV and MVA-Mosaic in Human Immunodeficiency Virus (HIV)-Infected Adults [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating safety and immunogenicity of a vaccine schedule using Ad26.Mos.HIV and MVA-Mosaic in HIV-infected adults; trial completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Ad26.Mos.HIV (Ad26.Mos.HIV vaccine)
• MVA-Mosaic (Modified Vaccinia Ankara HIV mosaic vaccine)

Snippet

Sponsor: Janssen Vaccines & Prevention B.V. | Conditions: Human Immunodeficiency Virus | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-03-11